Chantelle sells GWPH 89.04: BreedIT, Monsanto and GW Pharma Underscoring Advancements in Medical Marijuana Industry
Most investors are aware of the potential regulatory hurdles, but that has not steered them away from GW Pharmaceuticals (NASDAQ: GWPH). Probably the best biotech working with cannibinoids, GW Pharma has caught the attention of Wall Street for many reasons ... ...
64 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home